88 related articles for article (PubMed ID: 3336731)
1. Monitoring human tumor response to therapy by means of P-31 MR spectroscopy.
Semmler W; Gademann G; Bachert-Baumann P; Zabel HJ; Lorenz WJ; van Kaick G
Radiology; 1988 Feb; 166(2):533-9. PubMed ID: 3336731
[TBL] [Abstract][Full Text] [Related]
2. [In vivo 31 phosphorus spectroscopy of tumors: pre-, intra- and post-therapy].
Semmler W; Gademann G; Bachert-Baumann P; Bier V; Zabel HJ; Lorenz WJ; von Kaick G
Rofo; 1988 Oct; 149(4):369-77. PubMed ID: 2845503
[TBL] [Abstract][Full Text] [Related]
3. Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring. Work in progress.
Dewhirst MW; Sostman HD; Leopold KA; Charles HC; Moore D; Burn RA; Tucker JA; Harrelson JM; Oleson JR
Radiology; 1990 Mar; 174(3 Pt 1):847-53. PubMed ID: 2154837
[TBL] [Abstract][Full Text] [Related]
4. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment.
Segebarth CM; Balériaux DF; Arnold DL; Luyten PR; den Hollander JA
Radiology; 1987 Oct; 165(1):215-9. PubMed ID: 3628774
[TBL] [Abstract][Full Text] [Related]
5. Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization.
Schilling A; Gewiese B; Berger G; Boese-Landgraf J; Fobbe F; Stiller D; Gallkowski U; Wolf KJ
Radiology; 1992 Mar; 182(3):887-90. PubMed ID: 1311119
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
[TBL] [Abstract][Full Text] [Related]
7. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.
Naruse S; Hirakawa K; Horikawa Y; Tanaka C; Higuchi T; Ueda S; Nishikawa H; Watari H
Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of photoradiation therapy on brain tumors with in vivo P-31 MR spectroscopy.
Naruse S; Horikawa Y; Tanaka C; Higuchi T; Sekimoto H; Ueda S; Hirakawa K
Radiology; 1986 Sep; 160(3):827-30. PubMed ID: 3737923
[TBL] [Abstract][Full Text] [Related]
9. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy.
Semmler W; Bachert-Baumann P; Gückel F; Ermark F; Schlag P; Lorenz WJ; van Kaick G
Radiology; 1990 Jan; 174(1):141-5. PubMed ID: 2104675
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma: use of MR imaging and MR spectroscopy in clinical decision making.
Redmond OM; Stack JP; Dervan PA; Hurson BJ; Carney DN; Ennis JT
Radiology; 1989 Sep; 172(3):811-5. PubMed ID: 2772193
[TBL] [Abstract][Full Text] [Related]
11. P-31 spectroscopy study of response of superficial human tumors to therapy.
Karczmar GS; Meyerhoff DJ; Boska MD; Hubesch B; Poole J; Matson GB; Valone F; Weiner MW
Radiology; 1991 Apr; 179(1):149-53. PubMed ID: 2006266
[TBL] [Abstract][Full Text] [Related]
12. [In vivo 31P magnetic resonance spectroscopy and MRI in patients with superficial tumors].
Vogl T; Peer F; Reiman V; Holtmann S; Rennschmid C; Weber H; Hahn D; Lissner J
Rofo; 1989 Jan; 150(1):58-65. PubMed ID: 2536498
[TBL] [Abstract][Full Text] [Related]
13. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.
Sijens PE; Wijrdeman HK; Moerland MA; Bakker CJ; Vermeulen JW; Luyten PR
Radiology; 1988 Dec; 169(3):615-20. PubMed ID: 2847230
[TBL] [Abstract][Full Text] [Related]
14. Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy.
Vanel D; Lacombe MJ; Couanet D; Kalifa C; Spielmann M; Genin J
Radiology; 1987 Jul; 164(1):243-5. PubMed ID: 3588913
[TBL] [Abstract][Full Text] [Related]
15. [Rheumatoid arthritis of the hand. The initial results with 31-phosphorus MR spectroscopy].
Wacker F; Schilling A; Braun J; Bollow M; König H; Wolf KJ
Rofo; 1994 Jun; 160(6):559-63. PubMed ID: 8012003
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver.
Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH
Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002
[TBL] [Abstract][Full Text] [Related]
17. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy.
Ross B; Helsper JT; Cox IJ; Young IR; Kempf R; Makepeace A; Pennock J
Arch Surg; 1987 Dec; 122(12):1464-9. PubMed ID: 3479951
[TBL] [Abstract][Full Text] [Related]
19. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
[TBL] [Abstract][Full Text] [Related]
20. Variations in the in vivo P-31 MR spectra of the developing human brain during postnatal life. Work in progress.
Boesch C; Gruetter R; Martin E; Duc G; Wüthrich K
Radiology; 1989 Jul; 172(1):197-9. PubMed ID: 2740503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
